SANGRIX INC. Class A Ordinary Shares
SGRX
7 hedge funds and large institutions have $117K invested in SANGRIX INC. Class A Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
40% more funds holding
Funds holding: 5 → 7 (+2)
14% more capital invested
Capital invested by funds: $103K → $117K (+$14K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$14.2K |
| 2 |
Millennium Management
New York
|
+$10.7K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$7.11K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$14.2K |
SGRX Hedge Fund Activity: Q3 2022 in Review
7 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in SANGRIX INC. Class A Ordinary Shares (SGRX) for Q3 2022, worth a combined $117K — up 14% from $103K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SGRX positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, adding an estimated $14.2K. The largest seller was Citadel Advisors, cutting an estimated $14.2K.
- 7 institutional investors held SANGRIX INC. Class A Ordinary Shares (SGRX) as of Q3 2022, up from 5 in Q2 2022.
- Funds reported $117K of SANGRIX INC. Class A Ordinary Shares stock for Q3 2022, up 14% quarter-over-quarter.
- 2 funds opened new SANGRIX INC. Class A Ordinary Shares positions in Q3 2022 and 0 closed out, a net change of +2 holders.
- The largest SANGRIX INC. Class A Ordinary Shares buyer in Q3 2022 was Virtu Financial, an estimated $14.2K added.
- The largest SANGRIX INC. Class A Ordinary Shares seller in Q3 2022 was Citadel Advisors, an estimated $14.2K sold.
Based on aggregated 13F filings for Q3 2022.